Cell and Tissue Research

, Volume 319, Issue 2, pp 231–242 | Cite as

Estrogenic restoration of functional pancreatic islet cytoarchitecture in diabetes (db/db) mutant C57BL/KsJ mice: relationship to estradiol localization, systemic glycemia, and persistent hyperinsulinemia

Regular Article

Abstract

The diabetes (db/db) genotype mutation induces a hyperglycemic–hyperinsulinemic endometabolic state in C57BL/KsJ mice, manifesting a type 2 NIDDM diabetes-obesity syndrome (DOS) in this hyperphagic, leptin receptor (lf) defective model. The severity of the DOS induced by the single gene, homozygous-recessive mutation may be therapeutically moderated by gonadal steroids and pre-steroidal metabolites. The current studies define the estradiol (E2)-modulated phenotypic, systemic, cytochemical, and cellular metabolic responses to db/db mutation expression as compared to littermate control (+/?) indices. The db/db mutation induced dramatic age- and DOS severity-related increases in body weights, blood glucose, and serum insulin concentrations relative to +/? indices between 4-week-old (i.e., initial onset stage of DOS phenotype) and 16-week-old (i.e., chronic stage of DOS) groups. Chronic, low-dose (0.1μg/3.5 days) E2 treatment (E2-HRx) significantly reduced the obesity mass and blood glucose levels of db/db mutants relative to oil-HRx groups. Similarly, E2-HRx maintained pancreatic glucose utilization rates and pancreatic tissue weights in db/db mutants to near +/? indices. Concurrent amelioration of db/db-enhanced pancreatic lipogenesis and islet hypercytolipidemia occurred following E2-HRx. Pancreatic islet lipo-deposition was markedly reduced in db/db mutants following E2-HRx, and the restoration of islet size and cellular insulin concentrations correlated with β-cell cytoplasmic regranulation of insulin secretory vesicles. In chronic E2-HRx db/db groups, autoradiographic localization of 3H-E2 was demonstrated in the nuclear compartments of regranulated, nonhypertrophic islet cell populations, including insulin-containing β-cells. In chronic E2-HRx db/db mutants, β-cell insulin granulation was prominent in mildly hypertrophic pancreatic islets, with cytodistribution patterns and concentrations comparable to normal +/? indices. In contrast, E2-HRx maintained the systemic hyperinsulinemia characteristic of oil-HRx db/db mutants. The results of these studies indicate that the severity of the type 2 NIDDM endometabolic syndrome induced by the db/db genotypic mutation may be influenced by E2-HRx, including reduction of the islet hypercytolipidemia and hypertrophic atrophy which are indicators of impending pancreatic involution in this mutant model. The hypercytolipidemia-induced demise of β-cell cytoarchitecture was reduced by E2-HRx, including the reestablishment of islet β-cell cytogranulation. These data suggest that the severity of genomic db/db-mutation expression may be modified by E2-HRx, with the gonadal steroid probably acting as a nuclear-specific stimulatory transcriptional modulator of cellular glucometabolic cascades in the absence of leptin-directed homeostatic influences.

Keywords

Cellular glucose utilization Diabetes (db/db) mutation Estradiol autoradiography Hypercytolipidemia Hyperinsulinemia-hyperglycemia Pancreatic islet hypertrophic atrophy Mouse (C57BL/KsJ) 

Notes

Acknowledgements

The authors appreciate the excellent technical and scientific support provided by Douglas L. Coleman and Jessica Kueker during these studies.

References

  1. Bray GA, York DA (1979) Hypothalamic and genetic obesity in experimental animals: an autonomic and endocrine hypothesis. Physiol Rev 59:719–809PubMedGoogle Scholar
  2. Bruun JM, Nielsen CB, Pedersen SB, Flyvbjerg A, Richelsen B (2003) Estrogen reduces pro-inflammatory cytokines in rodent adipose tissue: studies in vivo and in vitro. Horm Metabol Res 35:142–146CrossRefGoogle Scholar
  3. Cefalu WT (2001) Insulin resistance: cellular and clinical concepts. Exp Biol Med 226:13–26Google Scholar
  4. Coleman DL (1978) Obese and diabetes: two mutant genes causing diabetes-obesity syndromes in mice. Diabetologia 14:141–148PubMedGoogle Scholar
  5. Coleman DL (1985) Antiobesity effects of eticholanolones in diabetes (db), viable yellow (Avy), and normal mice. Endocrinology 117:2279–2283PubMedGoogle Scholar
  6. Coleman DL, Leiter EH, Schwizer RW (1982) Therapeutic effects of dehydroepiandrosterone (DHEA) in diabetic mice. Diabetes 31:830–833PubMedGoogle Scholar
  7. Coleman DL, Leiter EH, Appleweig N (1984) Therapeutic effects of dehydroepiandrosterone (DHEA) metabolites in diabetes mutant mice (C57BL/KsJ-db/db). Endocrinology 115:239–243PubMedGoogle Scholar
  8. Cnop M, Hannaert JC, Hoorens A, Eizirik DL, Pipeleers DG (2001) Inverse relationship between cytotoxicity of free fatty acids in pancreatic Islet cells and cellular triglyceride accumulation. Diabetes 50:1771–1777PubMedGoogle Scholar
  9. Couce M, O’Brien TD, Moran A, Roche PC, Butler PC (1996) Diabetes mellitus in cystic fibrosis is characterized by islet amyloidosis. J Clin Endocrinol Metab 81:1267–1272CrossRefPubMedGoogle Scholar
  10. Ewart-Tolund A, Mounzih K, Qiu J, Chehab F (1999) Effect of the genetic background on the reproduction of leptin-deficient obese mice. Endocrinology 140:732–738CrossRefPubMedGoogle Scholar
  11. Gapp DA, Leiter EH, Coleman DL, Schwizer RL (1983) Temporal changes in pancreatic islet composition in C57BL/6J-db/db (diabetes) mice. Diabetologia 25:439–443CrossRefPubMedGoogle Scholar
  12. Garris DR (1985) Diabetes-associated alterations in uterine structure in the C57BL/KsJ mouse: relationship to changes in estradiol accumulation, circulating ovarian steroid levels and age. Anat Rec 211:414–419PubMedGoogle Scholar
  13. Garris DR (1987) Obese (ob/ob) and diabetes (db/db) mutations: two factors modulating brain and peripheral tissue accumulation of estradiol in C57BL/KsJ mice. Dev Brain Res 35:153–157CrossRefGoogle Scholar
  14. Garris DR (1988a) Effects of diabetes on uterine condition, decidualization, vascularization and corpus luteum function in the pseudopregnant rat. Endocrinology 122:665–672PubMedGoogle Scholar
  15. Garris DR (1988b) Reproductive tract and pancreatic norepinephrine levels in pre- and overt-diabetic C57BL/KsJ mice: relationship to body weight, blood glucose, serum insulin, and reproductive dysfunction. Proc Soc Exp Biol Med 189:79–83PubMedGoogle Scholar
  16. Garris DR (1988c) Nalmefene, an opiate antagonist, effectively modulates insulin receptor binding in peripheral tissues of C57BL/KsJ mice. Med Sci Res 16:301–303Google Scholar
  17. Garris DR (1989a) Effects of estradiol and progesterone on diabetes-associated utero-ovarian atrophy in C57BL/KsJ (db/db) mutant mice. Anat Rec 225:310–317PubMedGoogle Scholar
  18. Garris DR (1989b) Morphometric analysis of obesity (ob/ob) and diabetes (db/db) associated hypothalamic neuronal degeneration in C57BL/KsJ mice. Brain Res 501:162–170CrossRefPubMedGoogle Scholar
  19. Garris DR (1990a) The effects of estradiol and progesterone on reproductive tract atrophy and tissue adrenergic indices in diabetic C57BL/KsJ mice. Proc Soc Exp Biol Med 193:39–45PubMedGoogle Scholar
  20. Garris DR (1990b) Age- and diabetes-associated alterations in regional brain norepinephrine concentrations and adrenergic receptor populations in C57BL/KsJ mice. Dev Brain Res 51:161–166CrossRefGoogle Scholar
  21. Garris DR (1999) Estrogenic stimulation of hypothalamic-limbic system metabolism in ageing diabetic C57BL/KsJ mice. Neuroendocrinology 69:424–429CrossRefPubMedGoogle Scholar
  22. Garris DR (2004a) Variable onset determinants and consequences of diabetes (db/db)-obesity mutation: adrenergic promotion of utero-ovarian dysfunction. Horm Metabol Res 36:312–318CrossRefGoogle Scholar
  23. Garris DR (2004b) Hypercytolipidemia promotes diabetes (db/db) mutation-associated utero-ovarian involution: counter-regulatory influences of progesterone. Pathophysiology 11:41–50CrossRefPubMedGoogle Scholar
  24. Garris DR, Garris BL (2002) Lipoatrophic diabetes-associated utero-ovarian dysfunction: influence of cellular lipid deposition on norepinephrine indices. Horm Res 58:120–127CrossRefPubMedGoogle Scholar
  25. Garris DR, Garris BL (2003a) Diabetes-induced, progressive endometrial involution: characterization of periluminal epithelial lipoatrophy. Diabetes 52:51–58PubMedGoogle Scholar
  26. Garris DR, Garris BL (2003b) Diabetes (db/db) mutation-induced ovarian involution: progressive hypercytolipidemia. Exp Biol Med 228:1040–1050Google Scholar
  27. Garris BL, Garris DR (2004a) Digital chemospectrophotographic identification of intracellular hypercytolipidemia in diabetic endometrial epithelial cells: structural and metabolic basis of organoatrophy. Pathobiology 71:77–83CrossRefPubMedGoogle Scholar
  28. Garris DR, Garris BL (2004b) Cytolipotoxicity-induced involution of the female reproductive tract following expression of the obese (ob/ob) and diabetes (db/db) mutations: progressive, hypercytolipidemic transformation into adipocytic tissues. Reprod Tox 18:81–91CrossRefPubMedGoogle Scholar
  29. Garris DR, Garris BL (2004c) Cytochemical analysis of islet hypercytolipidemia following diabetes (db/db) and obese (ob/ob) mutation expression: influence of genetic background. Pathobiology 71:231–240Google Scholar
  30. Garris DR, Billiar RB, Takaoka Y, White RJ, Little B (1981) In situ estradiol and progestin (R5020) localization in the vascularly separated and isolated hypothalamus of the Rhesus monkey. Neuroendocrinology 32:202–208PubMedGoogle Scholar
  31. Garris DR, Coleman DL, Morgan CR (1985a) Age- and diabetes-related changes in tissue glucose uptake and estradiol accumulation in the C57BL/KsJ mouse. Diabetes 34:47–52Google Scholar
  32. Garris DR, Williams SK, West RL (1985b) Morphometric evaluation of diabetes-associated ovarian atrophy in the C57BL/KsJ mouse: relationship to age and ovarian function. Anat Rec 211:434–443PubMedGoogle Scholar
  33. Garris DR, West RL, Pekala PH (1986) Ultrastructural and metabolic changes associated with reproductive tract atrophy and adiposity in diabetic female mice. Anat Rec 216:359–366PubMedGoogle Scholar
  34. Geisler JG, Zawalich W, Zawalich K, Lakey JRT, Stukenbrok H, Milici AJ, Soeller WC (2002) Estrogen can prevent or reverse obesity and diabetes in mice expressing human islet amyloid polypeptide. Diabetes 51:2158–2169PubMedGoogle Scholar
  35. Gonzalez C, Alonso A, Grueso NA, Diaz F, Esteban MM, Fernandez S, Patterson AM (2001) Effect of treatment with different doses of 17-B-estradiol on insulin receptor substrate-1. J Pancreas 2:140–149Google Scholar
  36. Harris RBS (1999) Parabiosis between db/db and ob/ob or db/+ mice. Endocrinology 140:138–145CrossRefPubMedGoogle Scholar
  37. Kahn SE, Andrikopulos S, Verchere CB (1999) Islet amyloid: a long-recognized but unappreciated pathological feature of type 2 diabetes. Diabetes 48:241–253PubMedGoogle Scholar
  38. Koyama K, Chen G, Lee Y, Unger RH (1997) Tissue triglycerides, insulin resistance and insulin production: implications for hyperinsulinemia of obesity. Am J Physiol 273:E708–E713PubMedGoogle Scholar
  39. Krakower GR, Meier DA, Kissebah AH (1993) Female sex hormones, perinatal, and peripubertal androgenization on hepatocyte insulin dynamics in rats. Am J Physiol 264:E342–E347PubMedGoogle Scholar
  40. Leahy JL (1996) Impaired β-cell with chronic hyperglycemia: “overworked β-cell” hypothesis. Diabetes Rev 4:298–319Google Scholar
  41. Leibel RL, Chung WK, Chua Jr SC (1997) The molecular genetics of rodent single gene obesities. J Biol Chem 272:31937–31940CrossRefPubMedGoogle Scholar
  42. Lenzen S, Bailey CJ (1984) Thyroid hormones, gonadal and adrenocortical steroids and the function of the islets of Langerhans. Endocr Rev 5:411–434PubMedGoogle Scholar
  43. Like AA, Lavine RL, Peffenberger PL, Chick WL (1972) Studies in the diabetes mouse, IV: evaluation of glomerula lesions and associated proteinuria. Am J Pathol 66:193–224PubMedGoogle Scholar
  44. Machinal F, Dieudonne MN, Laneveu MC, Pecquery R, Giudicelli Y (1999) In vivo and in vitro ob gene expression and leptin secretion in rat adipocytes: evidence for a regional specific regulation by sex steroid hormones. Endocrinology 140:1567–1574CrossRefPubMedGoogle Scholar
  45. Morley JE (1988) Sex hormones and diabetes. Diabetes Rev 6:6–15Google Scholar
  46. Orland MJ, Permutt MA (1987) Quantitative analysis of pancreatic proinsulin mRNA in genetically diabetic (db/db) mice. Diabetes 37:341–347Google Scholar
  47. Roesler WJ, Khandelwal RL (1985) Age-related changes in hepatic glycogen metabolism in the genetically diabetic (db/db) mouse. Diabetes 34:395–402PubMedGoogle Scholar
  48. Shimabukuro M, Zhou YT, Levi M, Unger RH (1998) Fatty acid-induced β-cell apoptosis: a link between obesity and diabetes. Proc Natl Acad Sci U S A 95:2498–2502CrossRefPubMedGoogle Scholar
  49. Unger RH, Zhou YT (2001) Lipotoxicity of β-cells in obesity and in other causes of fatty acid spillover. Diabetes 50[Suppl 1]:118–121Google Scholar

Copyright information

© Springer-Verlag 2004

Authors and Affiliations

  1. 1.Division of Cell Biology and Biophysics, Schools of Biological Sciences and MedicineUniversity of Missouri–Kansas CityKansas CityUSA

Personalised recommendations